Intranasal Immunization with DNA Vaccine for SARS
Author Information
Author(s): Shim Byoung-Shik, Park Sung-Moo, Quan Ji-Shan, Jere Dhananjay, Chu Hyuk, Song Man Ki, Kim Dong Wook, Jang Yong-Suk, Yang Moon-Sik, Han Seung Hyun, Park Yong-Ho, Cho Chong-Su, Yun Cheol-Heui
Primary Institution: Seoul National University
Hypothesis
Can intranasal immunization with PEI/pci-S nanoparticles induce effective immune responses against SARS-CoV?
Conclusion
Intranasal immunization with PEI/pci-S nanoparticles induces antigen-specific humoral and cellular immune responses.
Supporting Evidence
- Mice immunized with PEI/pci-S nanoparticles produced significantly higher S-specific IgG1 and mucosal IgA.
- The number of B220+ cells was elevated in PEI/pci-S vaccinated mice.
- Co-stimulatory molecules and MHC class II molecules were increased on dendritic cells after vaccination.
Takeaway
The study shows that a new way of giving a vaccine through the nose can help the body fight off a virus called SARS.
Methodology
BALB/c mice were immunized intranasally with PEI/pci-S complexes and immune responses were measured.
Limitations
The study was conducted in mice, and results may not directly translate to humans.
Participant Demographics
Female BALB/c mice, aged six to eight weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website